Not applicableUnknownNCT03722875What this trial is testingSHR-1210 Plus Apatinib in Patients With Hepatocellular Carcinoma After SurgeryWho this might be right forHepatocellular Carcinoma Shanghai Zhongshan Hospital 45
Large-scale testing (Phase 3)UnknownNCT02755311What this trial is testingLiver Resection Versus Transarterial Chemoembolization for the Treatment of Intermediate-stage Hepatocellular CarcinomaWho this might be right forHepatocellular Carcinoma Sun Yat-sen University 198
Large-scale testing (Phase 3)Temporarily pausedNCT04268888What this trial is testingNivolumab in Combination With TACE/TAE for Patients With Intermediate Stage HCCWho this might be right forHepatocellular Carcinoma The Clatterbridge Cancer Centre NHS Foundation Trust 522
Not applicableStudy completedNCT07449065What this trial is testingCECT Features of MVI Predict Response to TACE Plus TKI in Intermediate-stage HCCWho this might be right forHepatocellular Carcinoma (HCC)Transarterial ChemoembolizationMicrovascular Invasion (MVI)+1 more First Affiliated Hospital, Sun Yat-Sen University 324
Large-scale testing (Phase 3)Study completedNCT04340193What this trial is testingNivolumab and Ipilimumab and Nivolumab Alone in Combination With Trans-arterial ChemoEmbolization (TACE) in Participants With Intermediate Stage Liver CancerWho this might be right forCancer, Hepatocellular Bristol-Myers Squibb 26
Post-approval studies (Phase 4)UnknownNCT00274885What this trial is testingRelationship Between Platinum Levels in the Blood and Neurotoxicity in Patients Who Are Receiving Oxaliplatin for Gastrointestinal CancerWho this might be right forCancer GERCOR - Multidisciplinary Oncology Cooperative Group 58
Testing effectiveness (Phase 2)Ended earlyNCT06848556What this trial is testingEvaluate the Effect of Tirazamine on Primary Liver Cancer.Who this might be right forHepato Cellular Carcinoma (HCC) Zhejiang Raygene Pharmaceuticals Co., Ltd 16
Large-scale testing (Phase 3)Ended earlyNCT04777851What this trial is testingRegorafenib-pembrolizumab vs. TACE/TARE in Intermediate Stage HCC Beyond Up-to-7Who this might be right forCarcinoma, Hepatocellular Translational Research in Oncology 45
Testing effectiveness (Phase 2)Looking for participantsNCT07501351What this trial is testingEfficacy and Safety Comparison Between Intensified Therapy and Conversion Therapy For Advanced HCC After Failure of First-lineWho this might be right forHepatocellulcar Carcinoma Sun Yat-sen University 80
Early research (Phase 1)Not Yet RecruitingNCT06994572What this trial is testingStudy of CT-01 as Monotherapy and Combination Therapy in Subjects With Intermediate or Advanced Hepatocellular CarcinomaWho this might be right forHepatocellular Carcinoma (HCC) Captor Therapeutics S.A. 141
Testing effectiveness (Phase 2)Study completedNCT03203005What this trial is testingIMA970A Plus CV8102 in Very Early, Early and Intermediate Stage Hepatocellular Carcinoma PatientsWho this might be right forHepatocellular Carcinoma National Cancer Institute, Naples 22
Large-scale testing (Phase 3)Looking for participantsNCT04803994What this trial is testingThe ABC-HCC Trial: Atezolizumab Plus Bevacizumab vs. Transarterial Chemoembolization (TACE) in Intermediate-stage HepatoCellular CarcinomaWho this might be right forHepatocellular Carcinoma Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest 434
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07682272What this trial is testingA Trial of SHR-8068 Combined With Adebrelimab and Apatinib in Perioperative Treatment of Resectable Hepatocellular CarcinomaWho this might be right forResectable Hepatocellular Carcinoma With Intermediate or High Recurrence Risk Suzhou Suncadia Biopharmaceuticals Co., Ltd. 120
Testing effectiveness (Phase 2)Study completedNCT04842565What this trial is testingCTACE Plus Sintilimab for Unresectable Intermediate-stage HCC With Beyond Up-to-seven CriteriaWho this might be right forHepatocellular Carcinoma Fudan University 20
Testing effectiveness (Phase 2)UnknownNCT01556815What this trial is testingSorafenib Combined With Transarterial Chemoembolization in Treating HBV-infected Patients With Intermediate Hepatocellular CarcinomaWho this might be right forPHENYTOIN/SORAFENIB [VA Drug Interaction]Liver NeoplasmsCarcinoma, Hepatocellular+9 more Shandong Cancer Hospital and Institute 40
Testing effectiveness (Phase 2)Active Not RecruitingNCT04522544What this trial is testingDurvalumab and Tremelimumab in Combination With Y-90 SIRT for Intermediate Stage HCCWho this might be right forHepatocellular Carcinoma Non-resectableHCC Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest 55
Testing effectiveness (Phase 2)Ended earlyNCT01381211What this trial is testingTransarterial RAdioembolization Versus ChemoEmbolization for the Treatment of Hepatocellular Carcinoma (HCC)Who this might be right forHepatocellular Carcinoma University Hospital, Ghent 72
Large-scale testing (Phase 3)UnknownNCT05220020What this trial is testingTACE Combined With Lenvatinib Versus TACE Sequential Lenvatinib in the Treatment of Intermediate/Advanced Liver CancerWho this might be right forHepatocellular Carcinoma Sun Yat-sen University 299
Testing effectiveness (Phase 2)Study completedNCT03572582What this trial is testingTransarterial Chemoembolization in Combination With Nivolumab Performed for Intermediate Stage Hepatocellular CarcinomaWho this might be right forCarcinoma, HepatocellularHepatic CarcinomaHepatocellular Cancer AIO-Studien-gGmbH 49
Large-scale testing (Phase 3)UnknownNCT03274427What this trial is testingTreatment of Intermediate-stage Hepatocellular CarcinomaWho this might be right forHCC The First Affiliated Hospital of Zhengzhou University 300